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 From August 20 to 25, 2008, Peter D. Hart Research Associates, Inc., 
conducted a nationwide survey among 1,003 adults about awareness of and 
attitudes toward both nanotechnology and synthetic biology. This is the third 
consecutive year a survey has been conducted about nanotechnology and the 
first year that questions have been asked about synthetic biology.  At the 
95% confidence level, the data's margin of error is ±3.1 percentage points. 
 
Two focus group sessions were conducted in Baltimore, Maryland, on August 6, 
2008, among adults—one among women and one among men—to explore both 
unaided and informed impressions of synthetic biology.  This qualitative 
research provides context for better understanding some of the survey findings 
about synthetic biology.   
 
 
Overview 
he large majority of Americans have little or no awareness of 
nanotechnology: less than one in four (24%) adults have heard some or 
a lot about it, including just 7% who have heard a lot, while three in four 
adults have heard just a little or nothing about it.  Nearly half (49%) of 
adults say that they have heard nothing at all about it.  There is a positive 
association between awareness of nanotechnology and the belief that the 
benefits of nanotechnology will outweigh the risks.  Those who are more 
familiar with the technology are more likely to think that the benefits will 
outweigh the risks, while large proportions of those who have heard a little or 
nothing at all about it do not express an opinion about it either way. 
 
Respondents were read a brief statement summarizing the potential benefits 
and risks of nanotechnology, and in both their initial and informed view of 
the tradeoff between risks and benefits, adults who are more familiar with 
nanotechnology are more likely to be optimistic that benefits will outweigh 
risks.  On the other hand, those who are less informed are notably more 
likely to move toward risks after hearing the statement. 
 
Public awareness of synthetic biology is considerably lower than that of 
nanotechnology.  Just less than one in 10 (9%) Americans say that they 
have heard some or a lot about it, including a mere 2% who have heard a 
lot, and 89% say they have heard just a little (22%) or nothing at all (67%).  
Despite their lack of familiarity with the subject, seven in 10 (71%) adults 
volunteer some description or association regarding what they think synthetic 
biology is.  Furthermore, two-thirds of those surveyed voice an initial opinion 
on the tradeoff of risks and benefits for synthetic biology.  Initially, 29% 
believe that there will be an equal tradeoff between risks and benefits of 
synthetic biology, and only slightly more believe that benefits will outweigh 
risks (21%) than believe risks will outweigh benefits (16%).  After hearing a 
statement describing potential risks and benefits of synthetic biology, 
however, the proportion of those who are inclined toward risks (35%) 
surpasses the proportion of those who are inclined toward benefits (28%), 
while the share of adults who think that the risks and benefits will be equal 
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remains the same.  As is similar to nanotechnology, those more familiar with 
synthetic biology are more inclined to have a positive assessment of the 
tradeoff. 
 
While nanotechnology and synthetic biology are at different stages in terms 
of their scientific development and current applications, a comparison of the 
American public’s uninformed and informed impressions of the risk-benefit 
tradeoff for each reveals that the public is more likely to form an opinion 
about the tradeoff for synthetic biology without knowledge of the science.  
Just as the public’s low level of familiarity with nanotechnology presents an 
opportunity for government, industry, and the scientific community to 
establish confidence in nanotechnology-enabled products, there is a similar 
opportunity with synthetic biology.  Indeed, there is perhaps an even greater 
risk in not beginning to inform the public about synthetic biology now before 
it is framed by misimpressions, misinformation, or skepticism. 
 
Key Findings 
 
ublic awareness of nanotechnology remains low, with three in 
four adults saying that they have heard just a little or nothing at 
all about it.  Nearly half (49%) of adults say that they have heard nothing 
at all about nanotechnology.  Today, 24% of Americans say they have heard 
a lot or some about nanotechnology, including just 7% who say they have 
heard a lot.  This represents a slight decline in awareness since last year 
(27% said they had heard a lot or some in 2007) and the year before (30% 
said they had heard a lot or some in 2006).  
Public Awareness Of Nanotechnology
17%
1%
49%
26%
7%
Heard 
a lot
Not 
sure
How much have you heard about nanotechnology?
Heard 
some
Heard 
just a little
Heard 
nothing
at all
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Echoing findings from previous polls, awareness of nanotechnology is 
greatest among men (33% heard a lot or some), especially men under  
age 50 (36%), as well as adults with higher incomes (32% among those with 
household incomes of more than $75,000) and education levels (36% among 
college graduates).  Nonetheless, the proportion reporting at least some 
awareness does not surpass 36% among any demographic group. 
 
Awareness is lowest among women, especially women age 50 and over (64% 
have heard nothing at all), adults who have acquired a high school degree or 
less education (68%), those whose annual household income is less than 
$30,000 (59%), and African Americans (68%).   
 
When those who express at least a minimal awareness of nanotechnology are 
asked where they heard about it, television is the top-tier source.  They also 
mention the Internet, magazines and journals, and news programs and 
newspapers.  Interestingly, adults with the highest level of awareness are 
most likely to cite magazines and journals as their information sources, while 
less-informed individuals are most likely to say that they heard about 
nanotechnology via television.    
 
 
early half of adults are too unsure about nanotechnology to 
make an initial assessment on the tradeoffs between risks and 
benefits.  Of those who are willing to make a judgment, by three to 
one they think that benefits will outweigh risks (20%) as opposed to 
thinking risks will outweigh benefits (7%).  The plurality, however, 
believe that risks and benefits will be about equal (25%).   
 
When asked to weigh the risks and benefits of nanotechnology in the 
absence of any definition or information about it, 48% of adults simply do 
not express an opinion.  One in four believes that the risks and benefits will 
be about equal, 20% think that the benefits will outweigh the risks, and just 
6% believe that the risks will outweigh the benefits.  
 
A comparison of the public’s initial, unaided impression of nanotechnology 
over the past three years reveals a slight trend toward a more positive 
assessment.  In 2006, 15% of adults said that the benefits will outweigh the 
risks, and that proportion increased to 18% last year.  There has been no 
shift in the proportion of adults who believe risks will outweigh benefits. 
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25%
48%
7%
20%
Initial Impression Of Risks And 
Benefits Of Nanotechnology
Benefits will 
outweigh risks
Benefits & 
risks will be 
about equal
Not 
sure
Risks will 
outweigh 
benefits 
Impact of Familiarity Prior to Survey
Benefits outweigh
Benefits/risks equal
Risks outweigh
Not sure
Heard 
a lot
49%
33%
8%
10%
Heard 
some
41%
26%
8%
25%
Heard 
a little
24%
29%
8%
39%
Heard 
nothing
8%
22%
5%
65%
 
 
 
There is a strong association between awareness of nanotechnology and 
respondents’ initial impression that the benefits will outweigh the risks.  
Those who have heard more about nanotechnology are more likely to think 
that the benefits will outweigh the risks.  Nearly half (49%) of those who 
have heard a lot about nanotechnology believe that the benefits will outweigh 
the risks, and the proportion who have this opinion decreases to 41% among 
those who have heard some about nanotechnology, 24% among those who 
have heard just a little, and just 8% among those who have not heard 
anything at all about it.  (Men, college graduates, and higher-income 
individuals report the highest levels of awareness of nanotechnology, and 
they are the groups most likely to think that benefits will outweigh risks.)   
 
A lack of awareness does not translate into greater skepticism of 
nanotechnology though.  Rather, two-thirds (65%) of adults who have not 
heard anything about the technology do not make a judgment on the risk-
benefit tradeoff. 
 
Across all demographic subgroups, respondents are more likely to think that 
the benefits will outweigh the risks than to have the opposing point of view.  
The groups who are the least convinced about the benefits are African 
Americans (16% benefits outweigh risks; 11% risks outweigh benefits; 24% 
both about equal) and evangelicals (16% benefits outweigh risks; 9% risks 
outweigh benefits; 29% both about equal). (See detailed table on page 7). 
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fter hearing a statement about both potential risks and potential 
benefits of nanotechnology, most adults are willing to express an 
opinion about these tradeoffs, and the largest proportion continue to 
think that the benefits and the risks will be about equal (38%).  
Nonetheless, the proportion of adults who think that the benefits will 
outweigh the risks increases, as does the proportion who think that 
the risks will outweigh the benefits.  Respondents were read the 
following information about nanotechnology, and then asked again to assess 
the tradeoff between benefits and risks. 
 
Nanotechnology is the ability to measure, see, predict, and make things on the extremely 
small scale of atoms and molecules.  Materials created at the nanoscale are called 
nanomaterials, and they often can be made to exhibit very different physical, chemical, 
and biological properties than their normal-sized counterparts. 
 
I would like to read you statements about the potential benefits and potential risks of 
nanotechnology and get your reaction.  
 
The potential BENEFITS of nanotechnology include the use of nanomaterials in products to 
make them stronger, lighter, and more effective.  Some examples are food containers that 
kill bacteria, stain-resistant clothing, high-performance sporting goods, faster, smaller 
computers, and more effective skin care products and sunscreens.  Nanotechnology also 
has the potential to provide new and better ways to treat disease, clean up the 
environment, enhance national security, and provide cheaper energy.   
 
While there has not been conclusive research on the potential RISKS of nanotechnology, 
there are concerns that some of the same properties that make nanomaterials useful 
might make them harmful. It is thought that some nanomaterials may be harmful to 
humans if they are breathed in and might cause harm to the environment. There also are 
concerns that invisible, nanotechnology-based monitoring devices could pose a threat to 
national security and personal privacy. 
 
After hearing this information there is a 10-point increase in the proportion of 
adults who think that the benefits will outweigh the risks (from 20% to 
30%), a 16-point increase in the share who think that the risks will outweigh 
the benefits (from 7% to 23%), and a 13-point increase in the proportion 
who say the benefits and the risks will be equal.  Just 9% remain unwilling to 
make a judgment. 
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38%
9%
23%
30%
Informed Impression Of Risks And 
Benefits Of Nanotechnology
Benefits will 
outweigh risks
Benefits & 
risks will be 
about equal
Not 
sure
Risks will 
outweigh 
benefits 
Benefits outweigh
Benefits/risks equal
Risks outweigh
Not sure
Heard 
a lot
55%
26%
16%
3%
Heard 
some
45%
28%
18%
9%
Heard 
a little
32%
44%
17%
7%
Heard 
nothing
19%
40%
29%
12%
Impact of Familiarity Prior to Survey
 
 
Reflecting trends in the previous two surveys, individuals with the greatest 
awareness of nanotechnology remain considerably more optimistic than other 
groups who think that the benefits will outweigh the risks.  The informed 
assessment of those who say that they had not heard anything about 
nanotechnology is less optimistic: this is the single group in which a larger 
proportion think that the risks will outweigh the benefits (29%) than think 
the benefits will outweigh the risks (19%).  This represents a 24-point shift 
toward risk.  (And whereas 65% of these individuals said they were not sure 
of the benefits versus risks in the initial question, only 12% said they were 
not sure in the informed question.) 
Peter D. Hart Research Associates, Inc. 
 
 
 Page 7 
 
Initial And Informed Impressions Of Nanotechnology 
 Initial Impressions Informed Impressions 
 
Benefits 
Outweigh 
Risks 
% 
Risks  
Outweigh 
Benefits 
% 
Risks 
And 
Benefits 
About 
Equal 
% 
Benefits 
Outweigh 
Risks 
% 
Risks  
Outweigh 
Benefits 
% 
Risks And 
Benefits About 
Equal 
% 
All adults 20 7 25 30 23 38 
Men 29 6 28 39 17 33 
Women 12 7 23 21 26 43 
Age 18 to 34 21 6 30 31 21 40 
Age 35 to 49 23 9 30 30 24 42 
Age 50 to 64 22 7 21 32 20 38 
Age 65 and over 14 6 18 23 28 31 
Men 18 to 49 31 7 30 41 18 32 
Men 50 and over 27 6 26 36 18 33 
Women 18 to 49 14 8 29 20 27 50 
Women 50 and 
over 12 6 16 21 29 37 
High school or 
less  13 4 29 20 25 44 
Some 
college/tech 17 9 25 27 26 37 
College grad or 
more 31 7 22 40 19 34 
Less than 
$30,000  14 7 28 22 32 37 
$30,000-50,000  14 6 34 25 21 47 
$50,000-$75,000  19 7 32 30 23 40 
More than 
$75,000  34 7 22 42 18 34 
Whites 21 6 24 31 27 36 
African 
Americans 16 11 24 17 23 51 
Hispanics 23 6 32 33 21 39 
Heard a lot 49 8 33 55 16 26 
Heard some 41 8 26 45 18 28 
Heard just a little 24 8 29 32 17 44 
Heard nothing 8 5 22 19 29 40 
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ynthetic biology is even more unknown than nanotechnology, 
with nearly nine in 10 Americans saying that they have heard 
just a little or nothing at all about it.  Just 9% of Americans say that they 
have heard a lot or some about this area of science, including a mere 2% 
who indicate they have heard a lot about it.  Another 22% of adults say they 
have heard just a little about synthetic biology, while fully 67% have heard 
nothing at all about it.   
 
Public Awareness Of 
Synthetic Biology
22%
2%
67%
9%
Heard a 
lot (2%)
or some
Not 
sure
How much have you heard about synthetic biology?
Heard 
just a little
Heard 
nothing
at all
 
 
While men (12%), college graduates (13%), and individuals with an annual 
household income over $75,000 (14%) report the highest levels of 
awareness, there is no demographic subgroup with more than 14% who say 
that they have heard at least some about synthetic biology.  The exception 
are individuals who say that they have heard a lot or some about 
nanotechnology—they are three times as likely as adults overall to say they 
have heard at least some about synthetic biology (26% heard a lot or some 
about synthetic biology). 
 
For the small proportion of Americans who express any awareness of 
synthetic biology, they are most likely to say that they heard about it on 
television, from the news media, or a newspaper.  The Internet, magazines 
and journals are second-tier sources.  
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espite their limited awareness of synthetic biology,  seven in 10 
Americans offer some remark about what they think synthetic 
biology is or what images, words, and phrases it conjures in their 
minds.  More than any other comment, adults mention some 
variation on the theme that synthetic biology is “man-made,” 
“artificial,” or “not natural.”  Respondents were asked the following open-
ended question: “Regardless of how much you have heard about synthetic 
biology, what do you think synthetic biology is?  What ideas, images, words, 
or phrases do you associate with synthetic biology?”  Nearly three in 10 
(29%) adults mention that synthetic biology is something man-made, 
artificial, fake, not natural, or not real.  One in 10 (11%) says that it has to 
do with cloning, genetic engineering, or genetic manipulation, another 7% 
say it has to do with altering biology or biological make-up, and 4% describe 
it as creating artificial life.  To the extent that they do focus on the 
applications and benefits without any prompting, adults are more likely to 
mention medical applications than other types of applications: 7% simply say 
it is used in medical research, and 6% say it is used to create human skin, 
organs, and tissue.   
 
Impressions of synthetic biology and the associations that individuals make 
with it were explored in greater detail in focus groups.  While only two 
sessions were conducted, impressions of what synthetic biology is mirror the 
responses in the survey. 
 
“Creating man-made items to replace naturally occurring living 
objects or cells.”  
–Baltimore woman 
 
“Anything that’s man made, science and the like, stuff like 
replacing what we call natural with the artificial.” 
–Baltimore man 
 
“It sounds like a man-made replacement for existing biological 
organisms or products, like everything from it almost seems 
artificial flavoring up to artificial tissue for the body.” 
 –Baltimore man 
 
“Robots.”  
–Baltimore woman 
 
“Cloning and stem cells and harvesting organs for the future.”  
–Baltimore man 
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ven with very low awareness of synthetic biology, a solid two-
thirds majority of adults are willing to express an initial opinion 
regarding the tradeoff between the potential benefits and risks of 
synthetic biology.  The American public approaches synthetic biology 
differently than they do nanotechnology: while they report a higher level of 
awareness of nanotechnology (49% have heard nothing at all about 
nanotechnology; 67% have heard nothing at all about synthetic biology), 
they actually are more willing to make an assessment of the synthetic 
biology risk-benefit tradeoff (52% express an opinion about the risks versus 
benefits of nanotechnology; 66% take a position on the risks versus benefits 
of synthetic biology).  
 
Just as with nanotechnology, respondents were asked to evaluate the risks 
and benefits of synthetic biology without receiving any information about it.  
They are slightly more likely to think that benefits will outweigh the risks 
(21%) than risks will outweigh the benefits (16%), while 29% believe that 
the risks and benefits will be equal. 
29%
34%
16%
21%
Initial Impression Of Risks And 
Benefits Of Synthetic Biology
Benefits will 
outweigh risks
Benefits & 
risks will be 
about equal
Not 
sure
Risks will 
outweigh 
benefits 
Benefits outweigh
Benefits/risks equal
Risks outweigh
Not sure
Heard a 
lot/some
41%
31%
12%
16%
Heard 
a little
25%
34%
17%
24%
Heard 
nothing
16%
27%
17%
40%
Impact of Familiarity Prior to Survey
 
 
Likewise, focus group participants recognize the possible benefits of synthetic 
biology, but hold serious concerns about the risk of unanticipated or 
uncontrollable consequences.  
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“I view it like sci-fi movies, where something is created in a 
laboratory, and it always seems great in the beginning, but 
down the line, something goes wrong because they didn’t think 
about this particular situation or it turning this way.”  
–Baltimore woman 
 
“It could help heal illnesses, feed the world, but there’s 
concern it could create plants or illnesses from it that can’t be 
controlled or cured, you know, same concerns we have in 
modifying genetics in people.”  
–Baltimore man 
 
As is the case with nanotechnology, those with greater familiarity of synthetic 
biology make a more positive assessment of the risks versus benefits.  Forty-
one percent of Americans who report hearing a lot or some about synthetic 
biology think that the benefits will outweigh the risks, compared with 25% 
who have heard just a little about it, and 16% among those who have not 
heard anything at all about it.  (Among those who have not heard anything 
about synthetic biology, 40% do not express an opinion about the risk-
benefit tradeoff.  That stands in contrast to nanotechnology: among those 
who have not heard anything about it, 65% do not give an evaluation.)  
 
There is a notable gender gap in Americans’ evaluation of the risk versus 
benefits tradeoff regarding synthetic biology, with men more positive (28% 
benefits will outweigh risks; 10% risks will outweigh benefits) than women 
(13% benefits will outweigh risks; 20% risks will outweigh benefits).  African 
Americans (11% benefits will outweigh risks; 16% risks will outweigh 
benefits) also are more skeptical than are whites (22% benefits will outweigh 
risks; 15% risks will outweigh benefits) and Hispanics (22% benefits will 
outweigh risks; 18% risks will outweigh benefits).  Groups that are evenly 
divided about the risks versus benefits include adults age 65 and over, those 
with less than a college education, those with an annual household income 
below $50,000, individuals who attend religious services weekly, and 
Evangelicals. (See table on page 13.) 
 
 
fter being informed of the potential risks and benefits of 
synthetic biology, the greatest shift in public opinion is toward 
risk, making this the plurality opinion.  Upon hearing the statement 
about synthetic biology (page 12), 29% of adults say that the risks and 
benefits are equal (no change from the initial question), 28% believe benefits 
outweigh risks (a seven-point increase), and 35% think that risks outweigh 
benefits (a 19-point increase).   
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Synthetic biology is the use of advanced science and engineering to make or re-design 
living organisms, such as bacteria, so that they can carry out specific functions.  Synthetic 
biology involves making new genetic code, also known as DNA, that does not already exist 
in nature.  
 
I would like to read you statements about the potential benefits and potential risks of 
synthetic biology and get your reaction. 
 
The potential BENEFITS of synthetic biology include developing new micro-organisms to 
treat disease, including cancer, more effectively and to create new and less expensive 
medications.  It also could be used to make new organisms that could provide cheaper and 
cleaner sources of energy than today's oil-based fuels, and to detect and break down 
environmental pollutants in the soil, air, and water.   
 
While the potential RISKS of synthetic biology are not known, there are concerns that 
man-made organisms might behave in unexpected and possibly harmful ways and that 
they could cause harm to the environment.  There also are concerns that, if these 
organisms fall into the wrong hands, they could be used as weapons.  Additionally, the 
ability to create artificial life has raised moral and ethical questions about how life is 
defined. 
 
29%
8%
35%
28%
Informed Impression Of Risks And 
Benefits Of Synthetic Biology
Benefits will 
outweigh risks
Benefits & 
risks will be 
about equal
Not 
sure
Risks will 
outweigh 
benefits 
Benefits outweigh
Benefits/risks equal
Risks outweigh
Not sure
Heard a 
lot/some
45%
27%
22%
6%
Heard 
a little
30%
30%
34%
6%
Heard 
nothing
24%
30%
37%
9%
Impact of Familiarity Prior to Survey
 
 
Evangelicals, women (especially those under 50), individuals who regularly 
attend religious services, lower-income and less-educated individuals are 
those most likely to think the risks outweigh the benefits.  Men, college-
educated individuals, those with an annual household income over $75,000, 
adults with no religious affiliation, and those who never attend religious 
services are the only demographic subgroups in which individuals are more 
likely to think that the benefits outweigh the risks than to have the opposite 
view. 
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Initial And Informed Impressions Of Synthetic Biology  
 Initial Impressions Informed Impressions 
 
Benefits 
Outweigh 
Risks 
% 
Risks  
Outweigh 
Benefits 
% 
Risks And 
Benefits 
About Equal 
% 
Benefits 
Outweigh 
Risks 
% 
Risks  
Outweigh 
Benefits 
% 
Risks And 
Benefits 
About Equal 
% 
All adults 21 16 29 28 35 29 
Men 28 10 30 35 29 30 
Women 13 20 30 20 41 29 
Age 18 to 34 22 15 31 28 34 34 
Age 35 to 49 25 17 31 29 39 26 
Age 50 to 64 18 16 30 29 34 30 
Age 65 and over 17 14 24 21 35 28 
Men 18 to 49 31 8 33 35 27 33 
Men 50 and over 25 15 25 34 31 26 
Women 18 to 49 16 25 28 22 45 26 
Women 50 and over 11 16 30 18 38 31 
High school or less  14 15 35 23 39 29 
Some college/tech 16 17 29 22 41 27 
College grad or 
more 29 16 25 35 29 31 
Less than $30,000  15 16 35 24 42 28 
$30,000-50,000  15 19 38 18 41 35 
$50,000-$75,000  22 17 31 30 41 25 
More than $75,000  29 15 26 35 28 31 
Whites 22 15 28 29 35 28 
African Americans 11 16 40 21 34 38 
Hispanics 22 18 30 28 37 29 
Attend religious 
services weekly 18 19 28 22 40 30 
Attend religious 
services less often 22 15 32 25 33 34 
Never attend 
religious services 23 9 31 41 29 23 
Protestants 19 16 31 24 36 32 
Catholics 22 17 32 28 37 27 
Other religion 21 21 23 29 33 31 
No religion 27 11 26 40 36 18 
Evangelicals 18 18 30 23 44 29 
Non-evangelicals 21 14 30 29 33 29 
Heard a lot/some 41 12 31 45 22 27 
Heard just a little 25 17 34 30 34 30 
Heard nothing 16 17 27 24 37 30 
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Focus group participants express a spectrum of views when it comes to their 
informed impression of the risks-benefits tradeoff. 
 
“Well, I guess I think that there’s not any advancements that 
we all use on a daily basis that when it first came out, that we 
didn’t think of as that’s scary and new.  I don’t think there’s 
any advancement that any of us, you know, our cell phones, 
our computers, our electricity…our automobiles, that when 
they first came out, people didn’t…have the same discussions 
that we’re having today about them.  I’m feeling this is similar 
to that, that with time, eventually, we’ll look back and see all 
the positives with it.  I mean, there are always going to be 
negatives as well, but I think every new advancement 
brings…brings a sense of fear and questioning whether we’re 
going in the right direction, and controversy.”  
–Baltimore woman 
  
“They identify a lot of risks, but then they also use these words 
that, things like ‘might,’ ‘potentially,’ there are questions.  So 
there’s all these advancements.  They don’t know what the side 
effects are going to be, and they may not be able to research it 
until these things have been around for 20 to 30 years.  And at 
that point, it’s maybe too late.  So I think there’s too many 
might’s and too many possibly’s for me to feel totally 
comfortable with all those things that have been identified on 
the other handout [about benefits].”  
–Baltimore woman 
 
“Well, to me, the most important benefits, I put the cleaning of 
the environment and creating biofuels.  And my concerns would 
be it getting into the wrong hands and the possible adverse 
environmental consequences.  I’ll give you an example is 
nuclear power, or nuclear technology.  We’re all concerned 
about who gets their hands on the weapons now.  It just kind 
of runs with that.” 
–Baltimore man 
 
